GHRP-1 vs Pentadeca Arginate (PDA)
GHRP-1: First-generation growth hormone-releasing hexapeptide; precursor to GHRP-2/-6.
Pentadeca Arginate (PDA): Arginate-salt analog of BPC-157 developed for improved injection stability and tissue repair.
GHRP-1
PerformanceFirst-generation growth hormone-releasing hexapeptide; precursor to GHRP-2/-6.
Top benefits
- Stimulates pituitary GH release
- Synergizes with GHRH analogs
- Lean mass support
Pentadeca Arginate (PDA)
RecoveryArginate-salt analog of BPC-157 developed for improved injection stability and tissue repair.
Top benefits
- Tendon and ligament healing
- Better stability than BPC-157 acetate
- Anti-inflammatory
| Attribute | GHRP-1 | Pentadeca Arginate (PDA) |
|---|---|---|
| Category | Performance | Recovery |
| Type | linear | linear |
| Chain length | 7 aa | 15 aa |
| Formula | C46H56N12O6 | BPC-157 arginate salt |
| Common dose | 100-300 mcg | 250-500 mcg |
| Frequency | 1-3x daily | 1-2x daily SC |
| Top benefit | Stimulates pituitary GH release | Tendon and ligament healing |
| Top side-effect | Mild cortisol/prolactin rise | Injection-site irritation |
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.